Lazard Asset Management
SRTS icon

Lazard Asset Management’s Sensus Healthcare SRTS Stock Holding History

Lazard Asset Management’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,769
Closed -$30K – 2524
2023
Q1 		$30K Buy
5,769
+454
+9% +$3.26K ﹤0.01% 1944
2022
Q4 		$39K Buy
5,315
+994
+23% +$8.97K ﹤0.01% 1918
2022
Q3 		$54K Sell
4,321
-2,160
-33% -$25.8K ﹤0.01% 1768
2022
Q2 		$49K Buy
+6,481
New +$54.4K ﹤0.01% 1821

Other funds holding SRTS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return

Lazard Asset Management's SRTS Position: Q2 2023 in Review

Lazard Asset Management sold out of Sensus Healthcare (SRTS) in Q2 2023, closing a stake of 5,769 shares — an estimated $30K sold.

Lazard Asset Management first reported a position in SRTS in Q2 2022 and held it in 4 quarters. The position peaked at $54K in Q3 2022. 49 funds tracked by Wall St. Rank hold SRTS as of Q2 2023.

  • Lazard Asset Management reported no remaining Sensus Healthcare position as of Q2 2023 after selling out during the quarter.
  • Lazard Asset Management sold 5,769 Sensus Healthcare shares in Q2 2023, an estimated $30K.
  • Lazard Asset Management first reported a position in Sensus Healthcare in Q2 2022 and held it in 4 quarters.
  • Lazard Asset Management's Sensus Healthcare position peaked at $54K in Q3 2022.
  • 49 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2023.

Based on Lazard Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.